Bernhard Gentner
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Hematology top 2%
Papers in
-
- MicroRNA in disease regulation 21
- Hematology 19
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 11
- Co-authors
- Luigi Naldini (46 shared papers)Mario Amendola (5 shared papers)Roberta Mazzieri (5 shared papers)Erika Zonari (8 shared papers)Davide Moi (3 shared papers)Brian D. Brown (2 shared papers)Ferdinando Pucci (3 shared papers)Alice Giustacchini (6 shared papers)
- Journals
- Blood (14 papers)Molecular Therapy (7 papers)Annals of Oncology (4 papers)Science Translational Medicine (4 papers)Cancer Cell (4 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Bernhard Gentner
91 papers receiving 5.5k citations
Bernhard Gentner's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 1.3k
- Hematology 727
- Immunology 1.3k
- Oncology 1.4k
- Molecular Biology 3.2k
Countries citing papers authored by Bernhard Gentner
This map shows the geographic impact of Bernhard Gentner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Gentner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Gentner more than expected).
Fields of papers citing papers by Bernhard Gentner
This network shows the impact of papers produced by Bernhard Gentner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Gentner. The network helps show where Bernhard Gentner may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernhard Gentner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells Hit paper breakdown → | 2011 | 545 |
| 2 | 2007 | 485 | |
| 3 | Targeted genome editing in human repopulating haematopoietic stem cells Hit paper breakdown → | 2014 | 482 |
| 4 | 2013 | 322 | |
| 5 | 2019 | 321 | |
| 6 | 2008 | 268 | |
| 7 | 2016 | 220 | |
| 8 | 2010 | 184 | |
| 9 | 2012 | 177 | |
| 10 | 2012 | 169 | |
| 11 | 2003 | 165 | |
| 12 | Genotoxic effects of base and prime editing in human hematopoietic stem cells Hit paper breakdown → | 2023 | 141 |
| 13 | 2022 | 138 | |
| 14 | 2017 | 132 | |
| 15 | 2013 | 126 | |
| 16 | 2013 | 110 | |
| 17 | 2014 | 101 | |
| 18 | 2018 | 90 | |
| 19 | 2009 | 78 | |
| 20 | 2017 | 72 |
About Bernhard Gentner
Bernhard Gentner is a scholar working on Cancer Research, Hematology, Immunology, Genetics and Molecular Biology, having authored 99 papers that have together received 5.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (26 papers), RNA Interference and Gene Delivery (23 papers), MicroRNA in disease regulation (21 papers), CRISPR and Genetic Engineering (19 papers), CAR-T cell therapy research (16 papers), Immune cells in cancer (13 papers), Acute Myeloid Leukemia Research (11 papers) and Hematopoietic Stem Cell Transplantation (11 papers). The work is most often cited by research in Cancer Research (1.3k citations), Hematology (727 citations), Immunology (1.3k citations), Oncology (1.4k citations) and Molecular Biology (3.2k citations). Bernhard Gentner has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Luigi Naldini, Mario Amendola, Roberta Mazzieri, Erika Zonari, Davide Moi, Brian D. Brown, Ferdinando Pucci, Alice Giustacchini, Letterio Salvatore Politi and Anna Ranghetti. Their work appears in journals such as Blood, Molecular Therapy, Annals of Oncology, Science Translational Medicine and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.